Pfizer's refocused efforts on danuglipron also ended in a decision to discontinue its development in April 2025 following a review of all available clinical trial data, regulatory input and after a single asymptomatic clinical trial participant exhibited potential drug-induced liver injury that resolved after the drug was withdrawn 25
Imbalanced redox states are increasingly recognized as underlying factors in major diseases, including cancers, neurodegenerative conditions, heart disease, and metabolic disorders [113]
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells
This manuscript synthesizes current advancements in MNP-based neuromodulation, examining its underlying mechanisms-such as localized heating, force generation, and electromagnetic induction-while highlighting its potential applications
If you're using such a product, the formulator has presumably addressed compatibility concerns